home *** CD-ROM | disk | FTP | other *** search
- $Unique_ID{BRK03997}
- $Pretitle{}
- $Title{Meningococcemia}
- $Subject{Meningococcemia Meningococcal Disease Meningococcemia-Meningitis
- Fulminant Meningococcemia Waterhouse-Friderichsen Syndrome Chronic
- Meningococcemia Rocky Mountain Spotted Fever Henoch-Schonlein Purpura Acute
- Vasculitis Rheumatic Fever Toxic Shock Syndrome Bacterial Endocarditis}
- $Volume{}
- $Log{}
-
- Copyright (C) 1992 National Organization for Rare Disorders, Inc.
-
- 916:
- Meningococcemia
-
- ** IMPORTANT **
- It is possible that the main title of the article (Meningococcemia) is
- not the name you expected. Please check the SYNONYM listing to find the
- alternate names and disorder subdivisions covered by this article.
-
- Synonyms
-
- Meningococcal Disease
- Meningococcemia-Meningitis
-
- Disorder Subdivisions:
-
- Fulminant Meningococcemia (also known as Waterhouse-Friderichsen
- Syndrome)
- Chronic Meningococcemia
-
- Information on the following diseases can be found in the Related
- Disorders section of this report:
-
- Rocky Mountain Spotted Fever
- Henoch-Schonlein Purpura
- Acute Vasculitis
- Rheumatic Fever
- Toxic Shock Syndrome
- Bacterial Endocarditis
-
- General Discussion
-
- ** REMINDER **
- The Information contained in the Rare Disease Database is provided for
- educational purposes only. It should not be used for diagnostic or treatment
- purposes. If you wish to obtain more information about this disorder, please
- contact your personal physician and/or the agencies listed in the "Resources"
- section of this report.
-
- Meningococcemia is an infectious disease that occurs rarely. However,
- there are years when epidemics of the illness occur. Major symptoms may
- include upper respiratory tract infection, fever, skin rash and lesions, eye
- and ear problems and possibly shock (a sudden state of extreme physical
- depression which could cause a life-threatening situation).
-
- Symptoms
-
- Meningococcemia is characterized by sudden intense headache, nausea, fever,
- vomiting, skin rash and in cases associated with meningitis, a stiff neck.
- The patient may first complain of an upper respiratory infection. Chills may
- develop, then skin rash on the arms or legs and the trunk. Diarrhea may also
- be present. Later the rash may become widespread or develop into bleeding
- spots under the skin (petechiae, ecchymoses, or purpura). There may be
- associated swelling, muscle pain, skin deterioration or gangrene in the arms
- and legs. Pneumonia may also develop along with the other symptoms if the
- person has a suppressed immune system.
-
- In cases where meningitis occurs along with meningococcemia, the patient
- may have the symptoms listed above along with the combination of headache,
- confusion, stiff neck, and muscle pain from irritation of membranes
- surrounding the brain and spinal cord (meningismus). (For more information
- on this disorder, choose "Meningitis" as your search term in the Rare Disease
- Database).
-
- Disorder Subdivision
-
- Fulminant Meningococcemia is also known as Waterhouse-Friderichsen
- Syndrome and is the most severe form of the disorder. The disease comes on
- very suddenly and the progression of the symptoms is very rapid. In less
- than a few hours the patient has very high fever, chills, weakness, vomiting
- and severe headache. A red rash appears on the arms and legs and spreads
- very quickly over the body including the eyes and nose. The patient's blood
- pressure may drop dangerously and the fever may also drop dramatically. The
- patient may go into shock. Without immediate medical treatment this disorder
- can be life-threatening.
-
- Chronic Meningococcemia is a rarer form of the disease. It is
- characterized by fever that comes and goes over a period of weeks or months.
- Muscle and joint pain with headache as well as a skin rash may also come and
- go. This form of the disorder may also include an enlarged spleen.
-
- Causes
-
- Meningococcemia is caused by infection with the meningococci bacteria
- (Neisseria memingitidis) which are gram-negative diplococci bacteria. There
- are various groups of this bacteria that cause different forms of the disease
- and they are grouped by strains A,B,C,D,X,Y,Z, 29E and W135. These groups
- can be identified by testing the blood, scrapings of the skin rash and
- samples of the cerebrospinal fluid of the patient. Testing may take up to
- five days as the cultures are very slow growing.
-
- Infection with the bacteria is usually caused by a carrier. The natural
- place for the bacteria to be located is in either the nose or throat of the
- carrier, and they can be spread by airborne or close contact methods. The
- carrier may spread the infection for weeks or months if they are not
- diagnosed and treated.
-
- Affected Population
-
- Meningococcemia affects males and females in equal numbers. However, most
- cases develop in persons twenty years of age or younger and half of these
- cases are in children under five years of age. In the United States 1.2
- cases per 100,000 occur annually. Winter and spring are the most common
- seasons of the year when cases are reported. Epidemics occur under crowded
- conditions and tend to occur at 20 to 30 year intervals. In other parts of
- the world epidemics are usually caused by the Group A strain of the bacteria.
- During epidemics, rates of 5 to 24 cases per 100,000 persons have occurred.
- In Sao Paulo, Brazil, during 1974 the epidemic rate was 370 per 100,000
- persons infected with Meningococcemia. In the United States, the most
- prevalent Group strains of the bacteria are B,C,Y, and W135.
-
- Related Disorders
-
- Symptoms of the following disorders can be similar to those of
- Meningococcemia. Comparisons may be useful for a differential diagnosis:
-
- Rocky Mountain Spotted Fever is a tick-borne disease that begins with an
- incubation period of from two to twelve days. A gradually or abruptly
- beginning fever may be followed after three to five days by a pink or
- purplish colored rash on the wrists and ankles. The fever and rash usually
- become more severe for seven to fourteen days. The rash may not develop in
- all cases, possibly making diagnosis difficult. A blood test is necessary to
- confirm the diagnosis. (For more information on this disorder, choose "Rocky
- Mountain" as your search term in the Rare Disease Database).
-
- Shoenlein-Henoch Purpura is one of a group of disorders characterized by
- purplish or brownish red discolorations on the skin. These spots may be
- large or small. Internal bleeding may occur in various areas of the body.
- This blood vessel disorder may affect the skin, joints, gastrointestinal
- system, kidneys, and in a very few cases the central nervous system. (For
- more information on this disorder, choose "Shoenlein-Henoch" as your search
- term in the Rare Disease Database).
-
- Vasculitis is a common disorder characterized by an inflammation of the
- blood vessel walls. This inflammation causes a narrowing of the inside of
- the vessel and can obstruct the flow of blood to the tissues. Red or purple
- patches of discoloration may develop under the skin. Arteries and veins of
- all sizes and in all parts of the body may be affected. It may be localized
- or affect multiple areas of the body with inflammatory and destructive
- lesions. There may be muscle pain, joint pain, fever, weight loss and loss
- of appetite, headache, and generalized weakness. (For more information on
- this disorder, choose "Vasculitis" as your search term in the Rare Disease
- Database).
-
- Rheumatic Fever is an inflammatory syndrome that can occur following a
- streptococcal infection. Patients initially experience moderate fever, a
- general feeling of ill health, a sore throat, fatigue and a red rash. Major
- complications can include heart disease, joint pain and arthritis,
- involuntary abrupt limb movements with characteristic grimaces and skin
- symptoms. (For more information on this disorder, choose "Rheumatic" as your
- search term in the Rare Disease Database).
-
- Toxic Shock Syndrome symptoms appear very suddenly. Initially, there is
- a fever of 102 to 105 degrees F, headache, sore throat, and conjunctivitis.
- Other early symptoms include profound lethargy, periods of disorientation,
- vomiting, severe diarrhea, and a diffuse sunburn-like rash leading to
- sloughing of skin after several days. In severe cases, the syndrome may
- progress to shock (dangerously low blood pressure and circulatory collapse)
- within forty-eight hours. (For more information on this disorder, choose
- "Toxic Shock" as your search term in the Rare Disease Database).
-
- Infective Endocarditis usually has a very sudden onset. Complaints of
- low back pain, pain in the joints (arthralgia) or in one or more muscles
- (myalgia) are common. These symptoms usually appear early in the disease,
- occasionally as the only initial symptoms. Fever, night sweats, chills,
- headache and loss of appetite may also occur. Blood or blood cells may be
- present in the urine (hematuria), small red or purple spots composed of blood
- (petechiae) may cover the skin of the upper trunk and there may also be pale,
- oval spots on the retina of the eye. (For more information on this disorder,
- choose "Endocarditis" as your search term in the Rare Disease Database).
-
- Therapies: Standard
-
- Meningococcemia is usually treated with Penicillin or Ampicillin. In adults
- the method of treatment is often through intravenous Penicillin G. In
- children penicillin is still the treatment of choice, however, other
- organisms must be ruled out before treatment is begun. For persons who are
- unable to take penicillin, other antibiotics are used such as: cefuroxime,
- cefotaxime or ceftriaxone.
-
- In persons who survive severe meningococcal septicemia there may be
- ongoing problems with veins and arteries. There are usually serious
- orthopedic problems. If gangrene occurs amputation may be necessary. These
- patients should have continuing medical evaluations as a precaution against
- other conditions that can arise in later years.
-
- During times of epidemics, chemoprophylaxis (Rifampin) is used to protect
- persons exposed to or in close contact with infected patients.
-
- Therapies: Investigational
-
- This disease entry is based upon medical information available through May
- 1992. Since NORD's resources are limited, it is not possible to keep every
- entry in the Rare Disease Database completely current and accurate. Please
- check with the agencies listed in the Resources section for the most current
- information about this disorder.
-
- Resources
-
- For more information on Meningococcemia, please contact:
-
- National Organization for Rare Disorders (NORD)
- P.O. Box 8923
- New Fairfield, CT 06812-1783
- (203) 746-6518
-
- NIH/National Institute of Allergy & Infectious Diseases (NIAID)
- 9000 Rockville Pike
- Bethesda, MD 20892
- (301) 496-5717
-
- Centers for Disease Control (CDC)
- 1600 Clifton Road, NE
- Atlanta, GA 30333
- (404) 639-3534
-
- References
-
- CECIL TEXTBOOK OF MEDICINE, 19th Ed.: James B. Wyngaarden, and Lloyd H.
- Smith, Jr., Editors; W.B. Saunders Co., 1990. Pp. 1611-1617.
-
- CLINICAL DERMATOLOGY, 2nd Ed.; Thomas P. Habif, M.D., Editor: The C.V.
- Mosby Company, 1990. Pp. 210-211.
-
- CHONDRO-OSSEOUS GROWTH ABNORMALITIES AFTER MENINGOCOCCEMIA, A CLINICAL
- AND HISTOPATHOLOGICAL STUDY., Grogan, D.P., et al.; J Bone Joint Surg (AM),
- July, 1989, (issue 71 (6)). Pp. 920-928.
-
-